Mackenzie Financial’s Immunomedics Inc IMMU Stock Holding History

Mackenzie Financial’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-19,414	Closed	-$1.65M	–	1119
2020 Q3	$1.65M	Sell	19,414 -20,585	-51%	-$1.04M	﹤0.01%	590
2020 Q2	$1.42M	Sell	39,999 -17,471	-30%	-$511K	﹤0.01%	620
2020 Q1	$775K	Buy	+57,470	New	+$967K	﹤0.01%	708
2019 Q1	–	Sell	-16,010	Closed	-$228K	–	1352
2018 Q4	$228K	Buy	+16,010	New	+$318K	﹤0.01%	1076

Mackenzie Financial's IMMU Position: Q4 2020 in Review

Mackenzie Financial sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 19,414 shares — an estimated $1.65M sold.

Mackenzie Financial first reported a position in IMMU in Q4 2018 and held it in 4 quarters. The position peaked at $1.65M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Mackenzie Financial reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Mackenzie Financial sold 19,414 Immunomedics Inc shares in Q4 2020, an estimated $1.65M.
Mackenzie Financial first reported a position in Immunomedics Inc in Q4 2018 and held it in 4 quarters.
Mackenzie Financial's Immunomedics Inc position peaked at $1.65M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Mackenzie Financial's 13F filing for Q4 2020, filed 10 Feb 2021.